Head to Head Study Against Sevelamer Hydrochloride

• Status: Completed
• Trial end date: 2008-07-31
• Target enrollment: 0
• Participant gender: All

Summary

To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shire
• Treatments: Sevelamer

Criteria

Inclusion Criteria:

• Adults with end stage renal disease who are receiving dialysis

Exclusion Criteria:

• Subjects with significant gastrointestinal disorders

• Subjects who are pregnant or nursing

• Subjects currently taking lanthanum carbonate, sevelamer hydrochloride, cinacalcet hydrochloride

• Subjects who are HIV positive

• Subjects with clinical significant liver disease